 |
196 Products |  |
52 Diseases | | 196 Products |
|
3529 Trials |  |
15381 News |  |
| «12...197198199200201202203204205206207208209 |
- |||| plinabulin (BPI 2358) / BeyondSpring
Trial completion: Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer (clinicaltrials.gov) - Aug 14, 2011
P1/2, N=172, Completed, Sponsor: Nereus Pharmaceuticals, Inc.
Active, not recruiting --> Completed
- henatinib / Shanghai Inst. of Materia Medica, Jiangsu Hengrui Pharma
New P1 trial, Metastases: A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies (clinicaltrials.gov) - Aug 11, 2011
P1, N=44, Terminated, Sponsor: Jiangsu HengRui Medicine Co., Ltd.